Do you want to read an article? Please log in or register.
Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US
Further Publications
Related content
Heart, Artery and Coronary DiseasesTherapy and Intervention
Contemporary Incidence and Procedural Volume of Transcatheter Aortic Valve Reintervention
JAMA Cardiol
Braasch MC, Pyeatte SR, He J, Rahimi M, Brescia AA, Kachroo P, Roberts HG Jr, Frogge N, Quader N, Sintek MA, Zajarias A, Kouchoukos N, Kaneko T
doi: 10.1001/jamacardio.2025.3224
Heart, Artery and Coronary DiseasesTherapy and Intervention
Prognostic impact of iliofemoral access-site calcification volume on outcomes after transcatheter aortic valve implantation
Clin Res Cardiol
Vij V, Schauwienold K, Shamekhi J, Muli S, Basha M, Markidis E, Zietzer A, Düsing P, Al Zaidi M, Weber M, Al-Kassou L, Zeus T, Mauri V, Adam M, Schröder J, Baldus S, Kelm M, Marx N, Bakhtiary F, Lüsebrink E, Zimmer S, Nickenig G, Sedaghat A, Al-Kassou B
doi: 10.1007/s00392-026-02956-w
Heart, Artery and Coronary DiseasesTherapy and Intervention
Real-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial Experience
JACC Cardiovasc Interv
Makkar RR, Gupta A, Inglessis I, Stinis CT, Yadav PK, Thourani VH, Chetcuti SJ, Summers M, Patel V, Chehab BM, Patel A, Tang GHL, Khera S, Rinaldi M, Simard T, Southard J, Stripe BR, Whisenant B, Allen K, Rozenman Y, Dvir D, Sanchez CE, Popma J, Leon MB, Généreux P
doi: 10.1016/j.jcin.2026.06.002
Heart, Artery and Coronary DiseasesTherapy and Intervention
First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective Study
JACC Cardiovasc Interv
Dvir D, Jilaihawi HA, Fraser D, Rodes-Cabau J, Nazif T, Mittal S, Grubb KJ, Gada H, Teiger E, Lin L, Rovin JD, Khalil RF, Sultan I, Yudi MB, Gardner B, Lorenz D, Chetcuti S, Patel NC, Harvey J, Mahoney P, Talreja D, Trani C, Mylotte D, Schwartz B, Jafar Z, Van der Heyden J, Maffeo D, Yong G, Valle-Fernández RD, Wang J, Gooley R, Yeh YJ, Yakubov SJ
doi: 10.1016/j.jcin.2026.05.007
Hypertension
Contemporary Prevalence and Treatment Patterns Among US Adults With Apparent Treatment-Resistant Hypertension
Hypertension
Earle WB, Watson NW, Juraschek SP, Cluett JL, Krawisz AK, Secemsky EA
doi: 10.1161/HYPERTENSIONAHA.125.25659
Cardiovascular Risk and Diseases
Extra-Virgin Olive Oil and Additional Cardiovascular Outcomes in the PREDIMED Trial: An Outcome-Wide Perspective
Am Heart J
de Rojas JP, Toledo E, Estruch R, Guasch-Ferré M, Salas-Salvadó J, Gómez-Gracia E, Ros E, Fitó M, Arós F, Fiol M, Lapetra J, Serra-Majem L, Pintó X, Sorlí JV, Babio N, Castañer O, Alonso-Gómez ÁM, Martínez-González MÁ, Jiménez-Moleón JJ
doi: 10.1016/j.ahj.2025.08.021
COMMENTED
Cardiovascular Risk and Diseases
Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Vazquez Arreola E, Gong Q, Hanson RL, Wang J, Sandforth L, He S, Sandforth A, Qian X, Giacca M, Bornstein SR, Fritsche A, Stefan N, Preissl H, Gregg EW, Marx N, Jumpertz-von Schwartzenberg R, Li G, Birkenfeld AL
doi: 10.1016/S2213-8587(25)00295-5
Atrial FibrillationThrombosis and Stroke
Long-Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry
J Am Heart Assoc
Higgins AY, Zimmerman S, Wang Y, Friedman DJ, Faridi KF, Price MJ, Reddy VY, Holmes DR Jr, Curtis JP, Freeman JV
doi: 10.1161/JAHA.124.039780
Myocardial Infarction
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries
Circ Cardiovasc Qual Outcomes
Mentias A, Keshvani N, Desai MY, Kapadia S, Ziada KM, McCarthy CP, Hall HM, Park K, Kumbhani DJ, Lincoff AM, Januzzi JL Jr, Pandey A
doi: 10.1161/CIRCOUTCOMES.125.012136